Comments
Loading...
PepGen Insider Trading Activity | NASDAQ:PEPG | Benzinga
Track the latest PepGen insider trading activity. Stay informed on recent buys, sells, and market impact for PepGen stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are PepGen Inc Insiders Doing?
At PepGen Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have report no sales in the last 30 days, meanwhile, insiders have reported buying a total of 41.50K shares for a total value of $47.72K.
Notable Recent Insider Buys and Sales
- On April 9, 2025, James McArthur, the company's PRESIDENT AND CEO purchased 41.5K shares for $1.15 each.
Ownership Statistics for PepGen Inc
Shares Outstanding
32.692M
Insider Shares Owned
125.933K
Insider Percentage Owned
0.39%
Institutional Shares Held
3.545M
Institutional Percentage Held
10.8%
| Apr 09, 2025 | James McArthur | PRESIDENT AND CEO | 41.50K | $1.15 | $47.72K | BUY | 66.49% | 103.91K | Apr 08 | View |
| Feb 26, 2025 | Beth Mary DeLena | GENERAL COUNSEL | 1.57K | $1.68 | -$2.41K | GRANT | ∞ | 1.57K | Feb 24 - Feb 26 | View |
| Feb 26, 2025 | Noel Donnelly | CHIEF FINANCIAL OFFICER | 1.67K | $1.68 | -$2.57K | GRANT | ∞ | 1.67K | Feb 24 - Feb 26 | View |
| Jul 26, 2024 | Michelle Mellion | CHIEF MEDICAL OFFICER | 0.00 | $14.13 | -$61.01K | SELL-OPTIONS | 0.00% | 0.00 | Jul 24 - Jul 25 | View |
| Jul 19, 2024 | Michelle Mellion | CHIEF MEDICAL OFFICER | 0.00 | $14.21 | -$100.90K | SELL-OPTIONS | 0.00% | 0.00 | Jul 18 | View |
| Jul 16, 2024 | Michelle Mellion | CHIEF MEDICAL OFFICER | 0.00 | $14.11 | -$71.76K | SELL-OPTIONS | 0.00% | 0.00 | Jul 12 - Jul 16 | View |
| Jul 03, 2024 | Michelle Mellion | CHIEF MEDICAL OFFICER | 0.00 | $14.11 | -$7.12K | SELL-OPTIONS | 0.00% | 0.00 | Jul 01 - Jul 02 | View |
| Jun 26, 2024 | Michelle Mellion | CHIEF MEDICAL OFFICER | 0.00 | $14.20 | -$73.88K | SELL-OPTIONS | 0.00% | 0.00 | Jun 24 | View |
| Jun 13, 2024 | Michelle Mellion | CHIEF MEDICAL OFFICER | 0.00 | $14.13 | -$12.44K | SELL-OPTIONS | 0.00% | 0.00 | Jun 11 - Jun 12 | View |
| Jun 07, 2024 | Michelle Mellion | SVP, CLINICAL DEVELOPMENT | 0.00 | $14.14 | -$68.08K | SELL-OPTIONS | 0.00% | 0.00 | Jun 05 - Jun 06 | View |
| May 17, 2024 | Niels Svenstrup | SVP, CHEM. MFG & CONTROLS | -10.00K | $13.41 | -$134.10K | SELL | -100.00% | 0.00 | May 17 | View |
| Feb 13, 2024 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 2.56M | $10.64 | $27.21M | BUY | 37.45% | 9.39M | Feb 09 | View |
| Dec 05, 2023 | James McArthur | PRESIDENT AND CEO | 1.69K | $4.17 | $7.06K | BUY | ∞ | 1.69K | Nov 30 | View |
| Jun 09, 2023 | James McArthur | PRESIDENT AND CEO | 0.00 | $9.37 | -$31.74K | SELL-OPTIONS | 0.00% | 0.00 | Jun 08 | View |
| Jun 08, 2023 | James McArthur | PRESIDENT AND CEO | 0.00 | $9.45 | -$358.28K | SELL-OPTIONS | 0.00% | 0.00 | Jun 06 - Jun 07 | View |
| Jun 06, 2023 | James McArthur | PRESIDENT AND CEO | 0.00 | $9.37 | -$30.66K | SELL-OPTIONS | 0.00% | 0.00 | Jun 02 - Jun 05 | View |
| Mar 28, 2023 | Jaya Goyal | EVP, RES. & PRECLIN. DEV. | 0.00 | $15.44 | -$3.58K | SELL-OPTIONS | 0.00% | 0.00 | Mar 24 | View |
| Feb 08, 2023 | Jaya Goyal | EVP, RES. & PRECLIN. DEV. | 0.00 | $14.00 | -$37.45K | SELL-OPTIONS | 0.00% | 0.00 | Feb 06 - Feb 08 | View |
| Jan 19, 2023 | LAURIE KEATING | DIRECTOR | 4.17K | $12.00 | $49.99K | BUY | ∞ | 4.17K | May 06 | View |
| May 12, 2022 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 8.13M | $12.00 | $38.75M | BUY | ∞ | 207.67K | May 10 | View |
| May 10, 2022 | James FlynnDeerfield Mgmt LPDEERFIELD PARTNERS LPDEERFIELD MANAGEMENT COMPANY LP SERIES CDeerfield Mgmt V LPDeerfield Private Design Fund V LP | 10% OWNER | 953.63K | $12.00 | $5.00M | BUY | ∞ | 476.81K | May 10 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.